The Fortis Helthcare Board, which is meeting on Thursday, will consider all proposals received so far which includes revised offers from Malaysia’s IHH Healthchare Berhad and the joint bidders Hero Enterprise Investment Office and Burman Family Office.

“It is hereby informed that the company today has received a supplemental proposal from IHH. As informed earlier, the Board of Directors of the company is scheduled on to meet on April 19,2018,” to consider all options,” according to a notification submitted by Fortis Healthcare to the Bombay Stock Exchange on Thursday.

As per IHH’s revised offer, the company is ready to infuse up to Rs 4,000 crore through a preferential allotment of equity shares at a price not exceeding Rs 160 per share which will fund the buyout of RHT assets as well as provide immediate liquidity towards working capital and infrastructure upgrades.

The Munjal-Burman family, too, has reportedly increased its offer to Rs 1,500 cr as compared to Rs 1,250 cr last week.

Early this week, Fortis confirmed that it had also received an offer from China's Fosun at a price of up to Rs 156 per share via primary infusion. The total investment by Fosun with this proposal will be up to $ 350 million and shall not enable the company to hold 25 per cent or more securities of Fortis, the company said in its proposal.

Manipal Hospital Enterprise Private Ltd (MHEPL) increased its offer to buy FHL’s hospital by about 21 per cent last week in response to opposition by minority shareholders who complained that the deal was undervalued. The new offer values Fortis' hospital business at ₹6,061 crore or ₹155 per share.

Related Topics